- 2024-08-20 02:10抑制剂Reuterin|Reuterin|2134-29-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Reuterin|Reuterin|2134-29-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RGD peptide (GRGDNP)|RGD peptide (GRGDNP)|114681-65-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂RET-IN-3|RET-IN-3|2414374-53-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Retro-2 cycl|Retro-2 cycl|1429192-00-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂Retro-2 cycl|Retro-2 cycl|1429192-00-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Reuterin|Reuterin|2134-29-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:10抑制剂Relenopride hydrochloride|Relenopride hydrochloride|1221416-42-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂RET-IN-3|RET-IN-3|2414374-53-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂RET-IN-3|RET-IN-3|2414374-53-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂RCM-1|RCM-1|339163-65-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂RCM-1|RCM-1|339163-65-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Relenopride hydrochloride|Relenopride hydrochloride|1221416-42-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂Relenopride hydrochloride|Relenopride hydrochloride|1221416-42-7|Adamas life|≥98%（以实测数值为准）|BR|25m
- 2024-08-20 02:10抑制剂Raxatrigine hydrochloride|Raxatrigine hydrochloride|934240-31-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:10抑制剂RBN-2397|RBN-2397|2381037-82-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:10抑制剂RBN-2397|RBN-2397|2381037-82-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Raf inhibitor 2|Raf inhibitor 2|220904-99-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:10抑制剂Ralfinamide mesylate|Ralfinamide mesylate|202825-45-4|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:10抑制剂Ralfinamide mesylate|Ralfinamide mesylate|202825-45-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
